Cowan Christopher B, Coté Gerard L, Good Theresa A
Chemical and Biochemical Engineering, University of Maryland, Baltimore County, UMBC 1000 Hilltop Circle, Baltimore, MD 21250, USA.
Biomaterials. 2008 Aug-Sep;29(24-25):3408-14. doi: 10.1016/j.biomaterials.2008.05.001. Epub 2008 Jun 3.
beta-Amyloid peptide (Abeta), the primary protein component in senile plaques associated with Alzheimer's disease (AD), has been implicated in neurotoxicity associated with AD. Previous studies have shown that the Abeta-neuronal membrane interaction plays a crucial role in Abeta toxicity. More specifically, it is thought that Abeta interacts with ganglioside rich and sialic acid rich regions of cell surfaces. In light of such evidence, we have hypothesized that the Abeta-membrane sialic acid interaction could be inhibited through use of a biomimic multivalent sialic acid compound that would compete with the cell surface for Abeta binding. To explore this hypothesis, we synthesized a series of photocrosslinked sialic acid containing oligosaccharides and tested their ability to bind Abeta and attenuate Abeta toxicity in cell culture assays. We show that a polymer prepared via the photocrosslinking of disialyllacto-N-tetraose (DSLNT) was able to attenuate Abeta toxicity at low micromolar concentrations without adversely affecting the cell viability. Polymers prepared from mono-sialyl-oligosaccharides were less effective at Abeta toxicity attenuation. These results demonstrate the feasibility of using photocrosslinked sialyl-oligosaccharides for prevention of Abeta toxicity in vitro and may provide insight into the design of new materials for use in attenuation of Abeta toxicity associated with AD.
β-淀粉样肽(Aβ)是与阿尔茨海默病(AD)相关的老年斑中的主要蛋白质成分,被认为与AD相关的神经毒性有关。先前的研究表明,Aβ与神经元膜的相互作用在Aβ毒性中起关键作用。更具体地说,人们认为Aβ与细胞表面富含神经节苷脂和唾液酸的区域相互作用。鉴于这些证据,我们推测可以通过使用一种生物模拟多价唾液酸化合物来抑制Aβ与膜唾液酸的相互作用,该化合物将与细胞表面竞争Aβ结合。为了探索这一假设,我们合成了一系列含唾液酸的光交联寡糖,并在细胞培养试验中测试了它们结合Aβ和减轻Aβ毒性的能力。我们表明,通过二唾液酸乳糖-N-四糖(DSLNT)光交联制备的聚合物能够在低微摩尔浓度下减轻Aβ毒性,而不会对细胞活力产生不利影响。由单唾液酸寡糖制备的聚合物在减轻Aβ毒性方面效果较差。这些结果证明了使用光交联唾液酸寡糖在体外预防Aβ毒性的可行性,并可能为设计用于减轻与AD相关的Aβ毒性的新材料提供见解。